Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CROWN CORONATION COVID-19 prevention trial
PACTR202101794986980Phase 3Not yet recruiting
- Sponsor
- Noguchi Memorial Institute for Medical Research
- Start
- Jan 2021
- Modality
- Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Vaccines & Immunotherapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of Measles and Rubella Vaccine (PT Bio Farma), ChAdOx1 nCoV-19 and Normal Saline-Benha University in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Noguchi Memorial Institute for Medical Research. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
Measles and Rubella Vaccine (PT Bio Farma)ChAdOx1 nCoV-19Normal Saline-Benha University
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202101794986980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202101794986980.